Improving Critical Care, One Molecule At A Time
TRIMEDIC THERAPEUTICS
Identify and address opportunities to improve outcomes for patients within the health care system
OUR APPROACH
Searching the world for products that will improve the quality of care and health outcomes for Canadians
COMPANY BACKGROUND
Headquartered in Toronto Canada, Trimedic Therapeutics Inc (TTI), was established in 2019 following the successful sale of Celopharma Inc., a pharmaceutical company founded by Marty Tenenbaum the principal partner of Celopharma, to a European international pharmaceutical industry leader in a multi million-dollar cash transaction.
The TTI Team are a small group of 12 experienced pharma executives with more than 200 years of collective expertise in the pharma industry. Our strong core values reflect hard work, honesty, integrity, transparency and a determination to improve health outcomes for Canadians.
TTI’s management team has a long history of creating significant value for all stakeholders and employees, at every opportunity.
Languages spoken include English, French, Spanish, Mandarin and Serbian.
SALES OFFICES AND DISTRIBUTION CENTRES ACROSS CANADA
Head Office & Sales Distribution – Toronto, Canada
Sales Office and Pharma Distribution Centre Canada – Quebec, East Coast
Sales Office – British Columbia West to Manitoba
KEY TEAM MEMBERS
MARTY TENENBAUM
BA, BBA
Schulich School
of Business, York
University, Toronto
CEO
SIMON JAY
B.Comm., MBA
Chief Commercial Officer
Pricing & Market Access,
Strategic Marketing
JOHN BOYACK
BSc Computer Science
Chief Sales & Technology
Officer, Devices and
Diagnostics
DR. CHARLES PIWKO
PharmD., PhD., MSc
Health Policy
Senior Clinical Consultant
ARAN KWINTA
LLB
York University
Osgoode Hall Law School
SAMMI CHAN
BA, CPA
University of Toronto
CFO
TOM OSTOJIC
Chief Regulatory Officer
Health Canada, FDA,
Provincial Regulatory
Processes
OLIVER KHAN
B.Comm.,
Queens University
Finance/Advisor
TRIMEDIC THERAPEUTICS
116-B Viceroy Road, Unit 1, Concord, ON., L4K 2M2
Mon – Fri: 9am – 4:30pm EST